Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: A model for assessing the biological property of this peculiar phenotype of breast cancers

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 23-30

  Borras, M ^a   Lacroix, M ^a   Legros, N ^a   Leclercq, G ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Breast cancer; Cell lines; Estrogen receptor; Progesterone receptor

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; 16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 4 HYDROXYTAMOXIFEN; ANTIGESTAGEN; BINDING PROTEIN; ESTROGEN RECEPTOR; GESTAGEN; ONAPRISTONE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CANCER; BREAST TUMOR; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIGAND BINDING; MENINGIOMA; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SUCROSE GRADIENT;

BREAST NEOPLASMS; CELL DIVISION; CYTOSOL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONANES; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; PREGNENEDIONES; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030807919     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00285-1     Document Type: Article

References (28)

1. Saez S., Chouvet C. Influence of endogenous hormone levels on tumor estradiol and progesterone receptors. Recent Res. Cancer Res. 91:1984;150-156.
2. Clark G.M., McGuire W.L. Progesterone receptors and human breast cancer. Breast Cancer Res. Treat. 3:1983;157-163.
3. Pichon M.F., Milgrom E. Oestrogen receptor negative-progesterone receptor positive phenotype in 1211 breast tumors. Br. J. Cancer. 65:1992;895-897.
4. Keshgegian A.A. Biochemically estrogen receptor-negative, progesterone receptor positive breast carcinoma. Arch. Pathol. Lab. Med. 118:1994;240-244.
5. Blankenstein M.A., Blaauw G., Lamberts S.W.J., Mulder E. Presence of progesterone receptors and absence of oestrogen receptors in human intracranial meningioma cytosols. Eur. J. Cancer Clin. Oncol. 19:1983;365-370.
6. Devleeschouwer N., Olea-Serrano N., Leclercq G., Legros N., Heuson J.C. Induction of progesterone receptor in an estrogen, progesterone receptor-negative breast cancer cell line. J. Steroid Biochem. 24:1986;365-368.
7. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
8. Carson-Jurica M.A., Schrader W.T., O'Malley B.W. Steroid receptor family: structure and functions. Endocrine Rev. 11:1990;201-220.
9. Lippman M.P., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 43:1976;4549-4601.
10. EORTC Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur. J. Cancer. 16:1980;1513-1515.
11. Chong M.T., Lippman M.E. Effect of temperature, nucleotides and sodium molybdate on activation and DNA binding of estrogen glucocorticoids, progesterone and androgen receptors in MCF-7 human cancer cells. J. Receptor Res. 2:1982;575-600.
12. Leclercq G., Devleeschouwer N., Heuson J.C. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogen for the treatment of breast cancer. J. Steroid Biochem. 19:1983;75-85.
13. Burton K.A. A study of the conditions and mechanism of the diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62:1956;315-323.
14. Claussner A., Nedelec L., Nique F., Teusch G., Van de Velde P. 11β-aminoalkyl estradiols, a new series of pure antiestrogens. J. Steroid Biochem. Mol. Biol. 41:1992;609-614.
15. Saceda M., Lippman M.E., Chambon P., Lindsay R.L., Ponglikitmongkol M., Puente M., Martin M.B. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2:1988;1157-1162.
16. Borrás M., Hardy L., Lempereur F., El Khissiin A.H., Legros N., Gol-Winkler R., Leclercq G. Estradiol-induced down-regulation of estrogen receptor effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol. 48:1994;325-336.
17. Horwitz K.B., McGuire W.L. Nuclear estrogen receptors. Effects of inhibitors on processing and steady state levels. J. Biol. Chem. 255:1980;9699-9705.
18. Horwitz K.B., Mockus M.B., Lessey B.A. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell. 26:1982;633-642.
19. Van der Berg H.W., Lynch M., Martin J.H.J. The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. Eur. J. Cancer. 29A:1993;1771-1775.
20. Maass N., Eidman H., Arps H., Jonat W. Progesterone antagonist ZK 98.299 (Onapristone) inhibits growth of the estrogen receptor (ER) and progesterone receptor (PR) positive breast cancer cell line MCF-7. Tumordiagn. Ther. 15:1994;6-11.
21. Fuqua S.A.W., Fitzgerald S.D., Chamness G.C.et al. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51:1991;105-109.
22. Sluyser M. Role of estrogen receptor variants in the developement of hormone resistance in breast cancer. Clin. Biochem. 25:1992;407-414.
23. Koehorst S.G.A., Jacobs H.M., Tilanus M.G.T., Bauwens A.G.M., Thijssen J.H.H., Blankenstein M.A. Aberrant oestrogen receptor species in human meningioma tissue. J. Steroid Biochem. Mol. Biol. 43:1992;57-61.
24. Del Moral R., Fernandez J.C., Lopez-Gonzalez J.D., Gomez M., Ruiz De Almodovar J.M., Olea N., Pedraza V. Kinetics of cellular proliferation and hormonal receptors in Evsa-T breast cancer cell line. Rev. Esp. Fisiol. 47:1991;25-30.
25. Ignar-Torwbridge D.M., Pimentel M., Parker M.G., McLachlan J.A., Korach K.S. Peptide growth factors cross-talk with the estrogen receptor requires A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
26. Katzenellenbogen B.S., Norman M.J. Multihormonal regulation of the progesterine receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. Endocrinology. 126:1990;891-898.
27. Sumida C., Lecerf F., Pasqualini J.R. Control of progesterone receptors in foetal uterine cells in culture: effects of estradiol, progestins, antiestrogens, and growth factors. Endocrinology. 122:1988;3-11.
28. Aronica S.M., Katzenellenbogen B.S. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3′, 5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology. 128:1991;2045-2052.